| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.9 |